Proteomics and mass spectrometry: What have we learned about the heart?

Current Cardiology Reviews

Volumn 6, Issue 2, 2010, Pages 124-133

  Chugh, Shaan ^a   Suen, Colin ^a   Gramolini, Anthony ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REVIEW; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 77951613734     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310791162631     Document Type: Review

References (91)

1. Kislinger T, Emili A. Going global: protein expression profiling using shotgun mass spectrometry. Curr Opin Mol Ther 2003; 5(3): 285-293 (Pubitemid 37185348)
2. Peronnet E, Becquart L, Poirier F, Cubizolles M, Choquet-Kastylevsky G, Jolivet-Reynaud C. SELDI-TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction. Proteomics 2006; 6(23): 6288-6299 (Pubitemid 44935515)
3. Kim N, Lee Y, Kim H, et al. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics 2006; 6(4): 1237-1249 (Pubitemid 43305263)
4. Koomen JM, Wilson CR, Guthrie P, Androlewicz MJ, Kobayashi R, Taegtmeyer H. Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J Proteome Res 2006; 5(1): 177-182 (Pubitemid 43100810)
5. Gramolini AO, Kislinger T, Alikhani-Koopaei R, et al. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics 2008; 7(3): 519-533 (Pubitemid 351472462)
6. Weekes J, Wheeler CH, Yan JX, et al. Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999; 20(4-5): 898-906. (Pubitemid 29222448)
7. Buscemi N, Murray C, Doherty-Kirby A, Lajoie G, Sussman MA, Van Eyk JE. Myocardial subproteomic analysis of a constitutively active Rac1-expressing transgenic mouse with lethal myocardial hypertrophy. Am J Physiol 2005; 289(6): H2325-33. (Pubitemid 41698539)
8. Chen YQ, Bi F, Wang SQ, Xiao SJ, Liu JN. Porous silicon affinity chips for biomarker detection by MALDI-TOF-MS. J Chromatogr 2008; 875(2): 502-508
9. Wei YJ, Huang YX, Shen Y, et al. Proteomic analysis reveals significant elevation of heat shock protein 70 in patients with chronic heart failure due to arrhythmogenic right ventricular cardiomyopathy. Mol Cell Biochem 2009; 332(1-2): 103-111
10. Cieniewski-Bernard C, Mulder P, Henry JP, et al. Proteomic analysis of left ventricular remodeling in an experimental model of heart failure J Proteome Res 2008; 7(11): 5004-5016
11. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007; 115(8): 949-952
12. Bignami E, Landoni G, Crescenzi G, et al. Role of cardiac biomarkers (troponin I and CK-MB) as predictors of quality of life and long-term outcome after cardiac surgery. Ann Card Anaesth 2009; 12(1): 22-26
13. McGregor E, Dunn MJ. Proteomics of heart disease. Hum Mol Gen 2003; 12 Spec No 2: R135-44.
14. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250(10): 4007-4021
15. McGregor E, Dunn MJ. Proteomics of the heart: unraveling disease. Circ Res 2006; 98(3): 309-321
16. Lang SC, Elsasser A, Scheler C, et al. Myocardial preconditioning and remote renal preconditioning - identifying a protective factor using proteomic methods? Basic Res Cardiol 2006; 101(2): 149-158
17. Yan L, Vatner DE, Kim SJ, Ge H, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102(39): 13807-13812
18. Faber MJ, Dalinghaus M, Lankhuizen IM, et al. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics 2005; 5(10): 2519-2530 (Pubitemid 40966479)
19. Shen X, Zheng S, Thongboonkerd V, et al. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab 2004; 287(5): E896-905.
20. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004; 4(12): 3665-3685 (Pubitemid 39657447)
21. Barnouin K. Two-dimensional gel electrophoresis for analysis of protein complexes. Methods Mol Biol 2004; 261: 479-498
22. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2002; 2(1): 3-10. (Pubitemid 34273093)
23. Righetti PG, Castagna A, Antonioli P, Boschetti E. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 2005; 26(2): 297-319. (Pubitemid 40253785)
24. Guo Y, Fu Z, Van Eyk JE. A proteomic primer for the clinician. Proc Am Thorac Soc 2007; 4(1): 9-17.
25. Stanley BA, Neverova I, Brown HA, Van Eyk JE. Optimizing protein solubility for two-dimensional gel electrophoresis analysis of human myocardium. Proteomics 2003; 3(6): 815-820 (Pubitemid 36801666)
26. Robichaud S, Lalu M, Udenberg T, Schulz R, Sawicki G. Proteomics analysis of changes in myocardial proteins during endotoxemia. J Proteomics 2009; 72(4): 648-655
27. Bell JR, Kennington E, Fuller W, et al. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity. Am J Physiol 2008; 294(2): H613-21. (Pubitemid 351253272)
28. Arrell DK, Elliott ST, Kane LA, et al. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res 2006; 99(7): 706-714
29. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 2005; 382(3): 669-678 (Pubitemid 40890994)
30. Warren CM, Arteaga GM, Rajan S, Ahmed RP, Wieczorek DF, Solaro RJ. Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy. Proteomics 2008; 8(1): 100-105
31. Kline KG, Wu CC. MudPIT analysis: application to human heart tissue. Methods Mol Biol 2009; 528: 281-293
32. Edwards AV, White MY, Cordwell SJ. The role of proteomics in clinical cardiovascular biomarker discovery. Mol Cell Proteomics 2008; 7(10): 1824-1837
33. Washburn MP, Wolters D, Yates JR, 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19(3): 242-247
34. Cutillas PR, Vanhaesebroeck B. Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics 2007; 6(9): 1560-1573
35. Kislinger T, Cox B, Kannan A, et al. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006; 125(1): 173-186
36. Shi R, Kumar C, Zougman A, et al. Analysis of the mouse liver proteome using advanced mass spectrometry. J Proteome Res 2007; 6(8): 2963-2972 (Pubitemid 47310181)
37. Graumann J, Hubner NC, Kim JB, et al. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics 2008; 7(4): 672-683 (Pubitemid 351597479)
38. Shin YK, Lee HJ, Lee JS, Paik YK. Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography. Proteomics 2006; 6(4): 1143-1150 (Pubitemid 43305252)
39. Mootha VK, Bunkenborg J, Olsen JV, et al. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 2003; 115(5): 629-640 (Pubitemid 37508523)
40. Schirmer EC, Florens L, Guan T, Yates JR, 3rd, Gerace L. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 2003; 301(5638): 1380-1382
41. Andersen JS, Lam YW, Leung AK, et al. Nucleolar proteome dynamics. Nature 2005; 433(7021): 77-83.
42. Jullig M, Hickey AJ, Chai CC, et al. Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 2008; 8(12): 2556-2572
43. Hortin GL. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006; 52(7): 1223-1237
44. Reyzer ML, Caprioli RM. MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery. J Proteome Res 2005; 4(4): 1138-1142
45. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359(9306): 572-577 (Pubitemid 34178440)
46. Pinet F, Beseme O, Cieniewski-Bernard C, et al. Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis. Proteomics 2008; 8(9): 1798-1808 (Pubitemid 351678280)
47. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods 2007; 4(10): 828-833 (Pubitemid 350055580)
48. Arab S, Gramolini AO, Ping P, et al. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 2006; 48(9): 1733-1741 (Pubitemid 44648616)
49. Zong Y, Zhang S, Chen HT, Zong Y, Shi Y. Forward-phase and reverse-phase protein microarray. Method Mol Biol 2007; 381: 363-374
50. Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001; 20(16): 1981-1989 (Pubitemid 32458030)
51. Talapatra A, Rouse R, Hardiman G. Protein microarrays: challenges and promises. Pharmacogenomics 2002; 3(4): 527-536
52. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci USA 2007; 104(14): 5860-5865 (Pubitemid 47175624)
53. Kirkpatrick DS, Gerber SA, Gygi SP. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods 2005; 35(3): 265-273
54. Liao H, Wu J, Kuhn E, et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004; 50(12): 3792-3803 (Pubitemid 39643926)
55. Kuster B, Schirle M, Mallick P, Aebersold R. Scoring proteomes with proteotypic peptide probes. Nat Rev 2005; 6(7): 577-583 (Pubitemid 40943048)
56. Gerszten RE, Accurso F, Bernard GR, et al. Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol 2008; 295(1): L16-22.
57. Kislinger T, Rahman K, Radulovic D, Cox B, Rossant J, Emili A. PRISM, a generic large scale proteomic investigation strategy for mammals. Mol Cell Proteomics 2003; 2(2): 96-106.
58. Sandhu C, Connor M, Kislinger T, Slingerland J, Emili A. Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells. J Proteome Res 2005; 4(3): 674-689 (Pubitemid 40863256)
59. Havugimana PC, Wong P, Emili A. Improved proteomic discovery by sample pre-fractionation using dual-column ion-exchange high performance liquid chromatography. . J Chromatogr 2007; 847(1): 54-61. (Pubitemid 46216201)
60. Horvatovich P, Govorukhina N, Bischoff R. Biomarker discovery by proteomics: challenges not only for the analytical chemist. Analyst 2006; 131(11): 1193-1196 (Pubitemid 44655359)
61. Seam N, Gonzales DA, Kern SJ, Hortin GL, Hoehn GT, Suffredini AF. Quality control of serum albumin depletion for proteomic analysis. Clin Chem 2007; 53(11): 1915-1920 (Pubitemid 350036035)
62. Baussant T, Bougueleret L, Johnson A, et al. Effective depletion of albumin using a new peptide-based affinity medium. Proteomics 2005; 5(4): 973-977 (Pubitemid 40469027)
63. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 2009; 3(1): 33-44.
64. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107(19): 2403-2405
65. Quiles J, Roy D, Gaze D, et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003; 92(3): 322-324 (Pubitemid 36897723)
66. Kleinfeld AM, Prothro D, Brown DL, Davis RC, Richieri GV, DeMaria A. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol 1996; 78(12): 1350-1354 (Pubitemid 126657226)
67. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345(14): 1014-1021
68. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108(3): 275-281 (Pubitemid 36899016)
69. Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995; 26(1): 18-25.
70. Ikonomidis I, Athanassopoulos G, Lekakis J, et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation 2005; 112(21): 3272-3279 (Pubitemid 43739372)
71. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003; 93(4): 292-301.
72. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008; 321(5895): 1493-1495
73. Jacquet S, Yin X, Sicard P, et al. Identification of cardiac myosin binding protein C as a candidate biomarker of myocardial infarction by proteomic analysis. Mol Cell Proteomics 2009; 8(12):2687-2699
74. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1(11): 845-867
75. Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005; 112(25): 3868-3875
76. Beretta L. Proteomics from the clinical perspective: many hopes and much debate. Nat Method 2007; 4(10): 785-786
77. Zhang H, Liu AY, Loriaux P, et al. Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics 2007; 6(1): 64-71.
78. Stastny J, Fosslien E, Robertson AL, Jr. Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis 1986; 60(2): 131-139
79. You SA, Archacki SR, Angheloiu G, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics 2003; 13(1): 25-30.
80. Perlman DH, Bauer SM, Ashrafian H, et al. Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res 2009; 104(6): 796-804.
81. Zlatkovic J, Arrell DK, Kane GC, Miki T, Seino S, Terzic A. Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics 2009; 9(5): 1314-1325
82. Grant JE, Bradshaw AD, Schwacke JH, Baicu CF, Zile MR, Schey KL. Quantification of Protein Expression Changes in the Aging Left Ventricle of Rattus norvegicus. J Proteome Res 2009; ;8(9):4252-4263
83. Costa VM, Silva R, Tavares LC, et al. Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology 2009; 260(1-3): 84-96.
84. Ruse CI, Tan FL, Kinter M, Bond M. Intregrated analysis of the human cardiac transcriptome, proteome and phosphoproteome. Proteomics 2004; 4(5): 1505-1516
85. Sutak R, Xu X, Whitnall M, Kashem MA, Vyoral D, Richardson DR. Proteomic analysis of hearts from frataxin knockout mice: marked rearrangement of energy metabolism, a response to cellular stress and altered expression of proteins involved in cell structure, motility and metabolism. Proteomics 2008; 8(8): 1731-1741
86. Chu G, Kerr JP, Mitton B, et al. Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling. FASEB J 2004; 18(14): 1725-1727
87. Labugger R, Simpson JA, Quick M, et al. Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem 2003; 49(6 Pt 1): 873-879
88. Zabrouskov V, Ge Y, Schwartz J, Walker JW. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry. Mol Cell Proteomics 2008; 7(10): 1838-1849
89. Hamblin M, Friedman DB, Hill S, Caprioli RM, Smith HM, Hill MF. Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J Mol Cell Cardiol 2007; 42(4): 884-895
90. Duan X, Young R, Straubinger RM, et al. A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. J Proteome Res 2009; 8(6): 2838-2850
91. Meng C, Jin X, Xia L, et al. Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats. J Proteome Res 2009; 8(5): 2463-2475